Testing effectiveness (Phase 2)Study completedNCT00243061
What this trial is testing
AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma
Who this might be right for
Acral Lentiginous Malignant MelanomaCiliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small Size+8 more
National Cancer Institute (NCI) 24